NIH/National Institute of Allergy and Infectious Diseases

Diseases, Conditions, Syndromes

Severe COVID-19 may lead to long-term innate immune system changes

Severe COVID-19 may cause long-lasting alterations to the innate immune system, the first line of defense against pathogens, according to a small study. These changes may help explain why the disease can damage so many different ...

HIV & AIDS

Experimental mRNA HIV vaccine safe, shows promise in animals

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of ...

Medical research

Experimental treatment slows prion disease, extends life of mice

Scientists using an experimental treatment have slowed the progression of scrapie, a degenerative central nervous disease caused by prions, in laboratory mice and greatly extended the rodents' lives, according to a new report ...

HIV & AIDS

HVTN 505 vaccine induced antibodies nonspecific for HIV

A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...

HIV & AIDS

New insights into HIV latent cells yield potential cure targets

In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC) and their collaborators ...

HIV & AIDS

'Mississippi Baby' now has detectable HIV, researchers find

The child known as the "Mississippi baby"—an infant seemingly cured of HIV that was reported as a case study of a prolonged remission of HIV infection in The New England Journal of Medicine last fall—now has detectable ...

page 5 from 40